qi.yang管理团队
这个人很懒，什么都没有留下～
16
文章
0
粉丝
-
【Product for Licensing】The Phase II Small Molecule targeting IL-17 & IL-4Ra solves unmet medical needs in Psoriasis and Atopic Dermatitis
If interested, please contact DrugTimes BD Team at BD@drugtimes.cn
-
【Product for Licensing】The Phase I ready Small Molecule with FIC potential in IBD
If interested in this asset, please contact DrugTimes BD Team at BD@drugtimes.cn. Many thanks!
-
密码保护：【Product for Licensing】A bispecific molecule targeting TSLP and IL33
无法提供摘要。这是一篇受保护的文章。
-
【Product for Licensing】 A BIC Vaccine Adjuvant for Human and Animal Vaccines
If interested, please contact DrugTimes BD Team at BD@drugtimes.cn
-
【Product for Licensing】 A FIC TLR9 targeted ODN Immunomodulator for the Treatment of Allergic Diseases
If interested in this asset, please contact DrugTimes BD Team at BD@drugtimes.cn. Many thanks!
-
【产品出售】通过局部作用治疗炎症性肠病的FIC小分子创新药寻求合作
项目ID：BP-20240618-OR-061
如果您对该项目感兴趣，欢迎联系药时代BD团队！
点击查看更多
